Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 6;129(14):1913-1918.
doi: 10.1182/blood-2016-12-725804. Epub 2017 Feb 6.

Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia

Dario Campana  1 , Ching-Hon Pui  2   3
Affiliations
Review

Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia

Dario Campana et al. Blood. .
No abstract available

PubMed Disclaimer

References

    1. Bradstock KF, Janossy G, Tidman N, et al. Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukaemia. Leuk Res. 1981;5(4-5):301-309. - PubMed
    1. Campana D, Pui CH. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood. 1995;85(6):1416-1434. - PubMed
    1. Coustan-Smith E, Song G, Clark C, et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 2011;117(23):6267-6276. - PMC - PubMed
    1. Theunissen P, Mejstrikova E, Sedek L, et al. ; EuroFlow Consortium. Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia. Blood. 2017;129(3):347-357. - PMC - PubMed
    1. Campana D. Minimal residual disease monitoring in childhood acute lymphoblastic leukemia. Curr Opin Hematol. 2012;19(4):313-318. - PubMed

MeSH terms